النسخة على الإنترنت: "مخلفات بعض العقاقير البيطرية في الأغذية والحيوانات" (الورقة الخاصة بالأغذية والتغذية رقم 41)

Diflubenzuron Monograph

In the absence of adequate information on exposure to 4-chloroaniline (PCA), a genotoxic and carcinogenic metabolite and/or degradate of diflubenzuron, the Committee was unable to establish an ADI for diflubenzuron because it was not possible to assure itself that there would be an adequate margin of safety from its use as a veterinary drug. The Committee also noted that it was not possible to calculate a margin of exposure for PCA in the absence of adequate information on exposure to PCA. The Committee was unable to recommend MRLs for diflubenzuron, as an ADI could not be established.